series-b
Stage
1
Investors
About
InFlectis BioScience is a clinical-stage biotechnology company developing first-in-class therapies for rare neurological diseases by inhibiting the integrated stress response.
Explore InFlectis BioScience's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.